“Breaking Through the FDA” (Biosphere, 2021)
Innovative medical devices and diagnostics can get to patients and providers sooner under the U.S. Food and Drug Administration’s (FDA) Breakthrough Device Program. The program provides a special regulatory Breakthrough Device Designation for medical products that have the potential to more effectively treat or diagnose serious or life-threatening conditions. See the full article on page 19 >
Peer-reviewed Phase 2 Results Inform Ongoing Phase 3/Pivotal Trial of Celeste®...
PhotoPharmics, a clinical-stage medical device company developing...
PhotoPharmics Surpasses Enrollment Target with 350 Participants in...
Attendees invited to Booth #732 for pivotal trial updates and to discuss unmet...
Renowned leaders in neurology, movement disorders, and commercialization join...
New clinical sites open in Illinois, Florida, and Arizona; trial remains open...
Introduction Imagine waking up after a full night’s sleep, yet feeling as...
Introduction Did you know that unintentional weight loss and nutritional...
Introduction Receiving a Parkinson's disease diagnosis is a life-altering...
Introduction Did you know that at least 50% of people with Parkinson's Disease...
Introduction If you're living with Parkinson's disease (PD), you might have a...
The Unseen Struggle of Parkinson's at Night When we think of Parkinson's...